Author | Simon Chowdhury, MD | OncLive

Author | Simon Chowdhury, MD

Articles

Dr. Chowdhury on Pembrolizumab Plus Pazopanib in RCC

June 16, 2017

Video

Simon Chowdhury, MD, consultant medical oncologist specializing in urological cancer, Sarah Cannon Research Institute, United Kingdom, discusses the combination of pembrolizumab (Keytruda) and pazopanib (Votrient) in patients with renal cell carcinoma (RCC).

x